Back to results
US 12,594,283 B2Granted
Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug
AssigneesThe Medical College of Wisconsin, Inc., Aix-Marseille Universite
InventorsBalaraman Kalyanaraman, Gang Cheng, Micael Joël Hardy
Life of this patent
Estimating the term…
Abstract
The present invention provides novel mitochondria-targeted Atovaquone compounds (Mito-ATO), a mitochondria-targeted derivative of Atovaquone, and methods of using such compounds. Methods of treating cancer using mito-ATO are also provided. Methods of enhancing an anti-tumor immune response by administering mito-ATO are further provided.
Claims22
A mito-ATO compound of formula (I)
- wherein
- X is selected from an unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, C2-C20 alkenyl, phenyl, phenyl substituted C1-C20 alkyl, cycloalkyl substituted C1-C20 alkyl, an aminoacid, and polyethylene glycol (PEG);
- each Y is independently selected from —H, —CF3, methyl (Me), Cl, OMe, C(O)CH3, NO2, N(Me)2;
- R is selected from H, F, Cl, Br, and I;
- and
- Z− is selected from halogen, 2,2,2-trifluoroacetic acid (TFA), HO−, RCOO−, and acetic acid.
3 more elements
A mito-ATO compound of formula (II)
- wherein Cy is a cyclic compound selected from cycloalkyl and aryl, and R is Cl.
Dependencies are inferred from the claim text.